指南与共识临床生化质量管理与危急值分子诊断

常规医学实验室色谱质量管理应用指南:EFLM认证与ISO/CEN标准委员会视角

Guidance in the application of quality management in the field of chromatography in routine medical laboratories - EFLM Committee: Accreditation and ISO/CEN Standards point of view.
指南 / 共识 · Clin Chem Lab Med · 2026-06-22

该指南由欧洲临床检验医学联合会(EFLM)认证与ISO/CEN标准委员会制定,将ISO 15189:2022要求解读并映射至色谱方法,识别样品制备变异、色谱柱性能漂移和检测器校准等色谱特有风险,提出覆盖检验前、中、后全流程的结构化验证、文件记录与风险管理策略,并特别关注实验室自建色谱检测与欧洲体外诊断法规的衔接。

要点

  • 将ISO 15189:2022条款映射至色谱特有风险,指导质量与风险管理
  • 强调方法验证、溯源性和结果放行,覆盖检验前中后全流程
  • 实验室自建色谱检测应对齐欧洲体外诊断法规要求

核心结论

  • 通过将ISO 15189:2022置于色谱技术实际情境中,为实验室和评审员提供保障质量、降低不确定度并确保患者结果可靠性的实用工具,推动法规协调与色谱在医学实验室的常规应用。

研究设计与样本

  • 由EFLM认证与ISO/CEN标准委员会基于既往工作,审查ISO 15189:2022要求并结合色谱程序进行解读,识别色谱固有脆弱点并映射至相关质量与能力条款。

主要发现

  • 识别出样品制备变异、色谱柱性能漂移和检测器校准等色谱关键脆弱点,并将其映射至相关质量与能力条款。
  • 指南覆盖检验前、检验中和检验后阶段,强调溯源性、方法验证和结果放行。
  • 对采用色谱技术的实验室自建检测给予特别考虑,使其与欧洲体外诊断法规对齐。

临床怎么用

  • 实验室可将色谱特有风险映射至ISO 15189:2022质量与能力条款,建立结构化验证、文件记录和风险管理策略。
  • 针对实验室自建色谱检测,应按指南对齐欧洲体外诊断法规要求。
  • 评审员可借助该框架核查色谱方法的溯源性、方法验证与结果放行环节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chromatographic separation has become a critical analytical technique in routine laboratory medicine. Although several documents address standardisation in chromatography, they largely focus on industrial and pharmaceutical applications. Routine medical laboratories remain underserved, creating a need for guidance tailored to their specific context. This paper aims to provide technical guidance on applying ISO 15189:2022 requirements to chromatographic methods, ensuring quality and risk management across all laboratory phases. CONTENT: Building on previous work of the European Federation of Laboratory Medicine Committee on Accreditation and ISO/CEN Standards, we reviewed ISO 15189:2022 requirements and interpreted them in relation to chromatographic procedures. Key vulnerabilities inherent to chromatography - such as sample preparation variability, column performance drift, and detector calibration - were identified and mapped to relevant quality and competence clauses. SUMMARY AND OUTLOOK: The guidance highlights chromatography-specific risks and proposes structured verification, documentation, and risk management strategies. It addresses pre-analytical, analytical, and post-analytical phases, emphasizing traceability, method verification, and result of release. Special consideration is given to laboratory-developed tests using chromatographic techniques, aligning them with European in vitro diagnostic regulation. By contextualising ISO 15189:2022 within the technical realities of chromatography, this paper provides laboratories and auditors with practical tools to safeguard quality, reduce uncertainty, and ensure reliable patient results. The proposed framework advances regulatory harmonisation and supports the routine implementation of chromatography in medical laboratories.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Milinković N, Çubukçu HC, Kanellopoulos P, et al. Guidance in the application of quality management in the field of chromatography in routine medical laboratories - EFLM Committee: Accreditation and ISO/CEN Standards point of view. Clin Chem Lab Med. 2026. PMID: 42316763. doi:10.1515/cclm-2026-0531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。